Dergi
/
İmmünoloji ve Enfeksiyon
/
Tests für die Identifizierung neuer Antivirale gegen Blauzungenvirus
JoVE Journal
İmmünoloji ve Enfeksiyon
Bu içeriği görüntülemek için JoVE aboneliği gereklidir.  Oturum açın veya ücretsiz deneme sürümünü başlatın.
JoVE Journal İmmünoloji ve Enfeksiyon
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Please note that all translations are automatically generated. Click here for the English version.

Tests für die Identifizierung neuer Antivirale gegen Blauzungenvirus

13,800 Views

•

12:02 min

•

October 11, 2013

DOI:

10.3791/50820-v

DOI:
10.3791/50820-v

•

12:02 min
October 11, 2013

•

5 Views
, ,
1Division of Infectious Diseases, Department of Medicine,University of Alabama at Birmingham, 2Molette Laboratory for Drug Discovery, Department of Chemistry and Biochemistry,Auburn University

Özet

Automatically generated

Drei Assays, einschließlich des zytopathischen Effekts (CPE)-basierte Assays, Dosis-Wirkungs-Assay und Time-of-Addition (TOA)-Assay entwickelt, optimiert, validiert und genutzt, um neue antivirale Mittel gegen Blauzungenvirus (BTV) zu identifizieren, sowie um den möglichen Mechanismus-of-Aktion (MoA) für neu identifizierten antiviralen Medikamenten zu bestimmen.

Explore More Videos

Antiviral AssaysBTV AntiviralsCytopathic Effect (CPE) AssayDose-response AssayMechanism Of Action (ToA) AssayAntiviral ScreeningViral LifecycleCell Culture System

Read Article

Cite this Article

Gu, L., Schneller, S. W., Li, Q. Assays for the Identification of Novel Antivirals against Bluetongue Virus. J. Vis. Exp. (80), e50820, doi:10.3791/50820 (2013).

Download .ris file

Copy

Share Video

.

Copy